Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• HBV: An underprioritized public health threat
• As Guinea residents’ Ebola knowledge improves, misconceptions linger
• C. difficile persists most frequently in floor corners after disinfection
• California labs commonly use outdated CRE detection practices
• Dengvaxia concern flagged nearly 2 years before Philippines pulls dengue vaccine
• Diclofenac inferior to norfloxacin for symptomatic treatment of UTIs
• EPA approves use of bacterium for mosquito control
• FDA approves Heplisav-B for adults
• Flu vaccination in pediatric ED cost-effective
• H3N2 mutation responsible for reducing vaccine efficacy
• HPV vaccine prevents incurable childhood respiratory disease
• HSS highlights recent progress against antibiotic resistance
• Measles incidence remains low in US
• Most women diagnosed with HIV not linked to care
• Nine countries on track to end HCV by 2030, US not among them
• Q&A: ‘The fight is not over’ for HIV
• San Francisco reports record low number of new HIV diagnoses
• Self-administered therapy noninferior to direct observation for latent TB
• Single measles case places high economic burden on public health agencies
• Study indicates more transgender women than men take HIV tests
• Text messages increase flu vaccination rates
• Time from HIV infection to diagnosis cut 17% in US
• WHO: 10% of medicine in developing countries fake or substandard
• WHO asks farmers to stop using antibiotics in healthy animals
• WHO report: Progress on malaria slows, 2020 targets in danger
• With DAAs, cure rates similar in HCV/HIV coinfection, monoinfection
• Should all adults be vaccinated against HBV?
• Welcome to the new world order: A competitive HCV drug marketplace Michael S. Saag, MD
• Meningococcal infection: Worldwide evolution Matthew E. Levison, MD, FACP; Donald Kaye, MD, MACP
• FDA approves first two-drug HIV regimen, Juluca
• Need for ID specialists grows as new threats emerge
• ACP, CDC: Screen, vaccinate at-risk adults for HBV
• ART reduces HPV, cervical cancer in women with HIV
• C. difficile on the rise in the community
• Canada finds case of ceftriaxone-resistant gonorrhea
• Dental patients often prescribed inappropriate antibiotic prophylaxis
• Fecal carriage of mcr-1 positive Enterobacteriaceae rises in China
• FMT capsules noninferior to colonoscopy in preventing recurrent C. difficile
• Health care personnel frequently work with influenza-like symptoms
• Homemade alcoholic drink causes mass poisoning in Mozambique
• Long-term data do not support raltegravir as second-line HIV therapy
• Male virgins infected with HPV despite no intercourse
• Many health care workers do not know correct influenza precautions
• Mavyret effective for HCV genotypes 1, 4 in DAA-experienced patients
• Meningococcal disease declines 70% in US
• Nonedemic regions in Africa at high risk for viral hemorrhagic fever outbreaks
• Novel tool forecasts severity of coming influenza season
• Outpatient prescribing drives unnecessary antibiotic use for CAP
• Patient handwashing cuts C. difficile rate in hospital
• Patients often change behavior after recurrent C. difficile infection
• Philosophical, religious reasons fuel nonmedical vaccine exemption rates
• Raw fish salad causes outbreak of group B Streptococcus in Singapore
• Scarlet fever incidence hits 50-year high in England
• SHEA, CDC release guidance for epidemiologists in outbreaks
• States that relax Medicaid restrictions see increase in HCV treatment
• Treatment may prevent progressive brain injury in patients with HIV
• Unusual findings suggest hospital antibiotic use associated with increased susceptibility
• Water cultures more sensitive than swab cultures to detect Legionella
• Yellow fever outbreaks in nonhuman primates pose ‘considerable risk’ to humans
• Zinplava cost-effective for preventing recurrent CDI
• Global syphilis prevalence declines over 3 decades
• Asian tiger mosquito greater vector for Zika virus after second feeding
• Delayed appropriate therapy more harmful than CRE diagnosis
• Dengue vaccine shows promising results at 18 months
• GI, respiratory, skin disease top list among troops in Ebola response
• Group B Streptococcus estimated to cause nearly 150,000 stillbirths, infant deaths
• Malaria breath test shows promise in clinical trial
• Neurological abnormalities common in patients with West Nile virus